NO904987L - Fremgangsmaate for fremstilling av indolderivater. - Google Patents

Fremgangsmaate for fremstilling av indolderivater.

Info

Publication number: NO904987L
Authority: NO; Norway
Prior art keywords: indolidate; derivatives; procedure; preparation; indolidate derivatives
Prior art date: 1989-11-17

Application number

NO90904987A

Other languages

English (en)

Other versions

NO904987D0 (no

Inventor

Barry Clive Ross

David Middlemiss

David Ian Carter Scopes

Torquil Iain Maclean Jack

Kevin Stuart Cardwell

Michael Dessis Dowle

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-17

Filing date

1990-11-16

Publication date

1991-05-21

1989-11-17 Priority claimed from GB898926097A external-priority patent/GB8926097D0/en

1990-06-01 Priority claimed from GB909012276A external-priority patent/GB9012276D0/en

1990-11-16 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1990-11-16 Publication of NO904987D0 publication Critical patent/NO904987D0/no

1991-05-21 Publication of NO904987L publication Critical patent/NO904987L/no

Links

HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical class C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Cardiology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO90904987A 1989-11-17 1990-11-16 Fremgangsmaate for fremstilling av indolderivater. NO904987L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB898926097A GB8926097D0 (en)	1989-11-17	1989-11-17	Chemical compounds
GB909012276A GB9012276D0 (en)	1990-06-01	1990-06-01	Chemical compounds

Publications (2)

Publication Number	Publication Date
NO904987D0 NO904987D0 (no)	1990-11-16
NO904987L true NO904987L (no)	1991-05-21

Family

ID=26296224

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO90904987A NO904987L (no)	1989-11-17	1990-11-16	Fremgangsmaate for fremstilling av indolderivater.

Country Status (11)

Country	Link
EP (1)	EP0429257A3 (no)
JP (1)	JPH03271288A (no)
KR (1)	KR910009692A (no)
AU (1)	AU638510B2 (no)
CA (1)	CA2030177A1 (no)
FI (1)	FI905672A7 (no)
IE (1)	IE904146A1 (no)
IL (1)	IL96385A0 (no)
NO (1)	NO904987L (no)
NZ (1)	NZ236117A (no)
PT (1)	PT95899A (no)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0430709A3 (en) *	1989-12-01	1992-02-12	Glaxo Group Limited	Benzthiophen derivatives
US5449682A (en) *	1990-02-13	1995-09-12	Merck & Co., Inc.	Angiotensin II antagonists incorporating a substituted benzyl element
US5183810A (en) *	1990-02-13	1993-02-02	Merck & Co., Inc.	Imidazole angiotensin II antagonists incorporating a substituted benzyl element
US5177095A (en) *	1990-02-13	1993-01-05	Merck & Co., Inc.	Triazole angiotensin II antagonists incorporating a substituted benzyl element
US5240938A (en) *	1991-02-13	1993-08-31	Merck & Co., Inc.	Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring
EP0443983B1 (de) *	1990-02-19	1996-02-28	Ciba-Geigy Ag	Acylverbindungen
GB9022858D0 (en) *	1990-10-20	1990-12-05	Reckitt & Colmann Prod Ltd	Derivatives of indoles
PH31175A (en) *	1990-10-31	1998-03-20	Squibb & Sons Inc	Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.
CA2061159A1 (en) *	1991-02-26	1992-08-27	Michael A. Poss	Imidazole and benzimidazole derivatives
US5236928A (en) *	1991-03-19	1993-08-17	Merck & Co., Inc.	Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists
US5187179A (en) *	1991-03-22	1993-02-16	Merck & Co., Inc.	Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole
US5128327A (en) *	1991-03-25	1992-07-07	Merck & Co., Inc.	Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
US5177074A (en) *	1991-03-26	1993-01-05	Merck & Co., Inc.	Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5151435A (en) *	1991-04-08	1992-09-29	Merck & Co., Inc.	Angiotensin ii antagonists incorporating an indole or dihydroindole
US5252574A (en) *	1991-04-26	1993-10-12	Merck & Co., Inc.	Angiotensin II antagonists incorporating a substituted thiophene or furan
US5198438A (en) *	1991-05-07	1993-03-30	Merck & Co., Inc.	Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5175164A (en) *	1991-06-05	1992-12-29	Merck & Co., Inc.	Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
GB9113626D0 (en) *	1991-06-25	1991-08-14	Ici Plc	Heterocyclic compounds
GB9113628D0 (en) *	1991-06-25	1991-08-14	Ici Plc	Heterocyclic derivatives
DK0528762T3 (da) *	1991-08-15	1997-08-25	Ciba Geigy Ag	N-acyl-N-heterocyclyl- eller naphthylalkyl-aminosyrer som angiotensin II antagonister
US5187159A (en) *	1991-10-07	1993-02-16	Merck & Co., Inc.	Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
US5212177A (en) *	1991-12-16	1993-05-18	E. R. Squibb & Sons, Inc.	Indole and benzimidazole-substituted dihydropyrimidine derivatives
US5364869A (en) *	1992-03-09	1994-11-15	Abbott Laboratories	Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists
US5208235A (en) *	1992-03-10	1993-05-04	E. R. Squibb & Sons, Inc.	Indole- and benzimidazole-substituted imidazole derivatives
US5208234A (en) *	1992-03-10	1993-05-04	E. R. Squibb & Sons, Inc.	Substituted imidazole phosphonic and phosphinic acid derivatives
EP0602246A4 (en) *	1992-03-25	1995-07-05	Green Cross Corp	Isoindazole derivatives.
EP0597112A4 (en) *	1992-03-27	1994-06-22	Kyoto Pharma Ind	Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor.
US5616591A (en) *	1992-03-27	1997-04-01	E.R. Squibb & Sons, Inc.	Indole- and benzimidazole-substituted quinoline derivatives
US5538973A (en) *	1992-03-27	1996-07-23	Kyoto Pharmaceutical Industries, Ltd.	Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
US5294722A (en) *	1992-04-16	1994-03-15	E. R. Squibb & Sons, Inc.	Process for the preparation of imidazoles useful in angiotensin II antagonism
US5236916A (en) *	1992-05-26	1993-08-17	E. R. Squibb & Sons, Inc.	Oxadiazinone substituted indole and benzimidazole derivatives
US5401851A (en) *	1992-06-03	1995-03-28	Eli Lilly And Company	Angiotensin II antagonists
US5612360A (en) *	1992-06-03	1997-03-18	Eli Lilly And Company	Angiotensin II antagonists
FR2693197B1 (fr) *	1992-07-03	1994-09-23	Synthelabo	Nouveaux dérivés de quinoléine, leur procédé de préparation et leur application thérapeutique.
GB9218449D0 (en)	1992-08-29	1992-10-14	Boots Co Plc	Therapeutic agents
US5284841A (en) *	1993-02-04	1994-02-08	Merck & Co., Inc.	Benzo-fused lactams promote release of growth hormone
DE59403903D1 (de) *	1993-03-12	1997-10-09	Lonza Ag	Verfahren zur Herstellung von gegebenfalls 2-substituierten 5-Chlorimidazolen
US5484939A (en) *	1993-03-12	1996-01-16	Lonza Ltd.	2-substituted 5-chlorimidazoles
SG72827A1 (en) *	1997-06-23	2000-05-23	Hoffmann La Roche	Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
HUP0104987A3 (en) *	1998-12-18	2002-09-30	Axys Pharmaceuticals Inc South	Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
SE9903028D0 (sv)	1999-08-27	1999-08-27	Astra Ab	New use
JP2004502642A (ja)	2000-02-11	2004-01-29	ブリストル−マイヤーズ　スクイブ　カンパニー	カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
EP1724271A4 (en)	2004-02-26	2013-01-23	Kyowa Hakko Kirin Co Ltd	PREVENTIVE AND / OR THERAPEUTIC AGENT AGAINST NEUTROPHIC INFLAMMATORY DISEASE
BRPI0512252A (pt)	2004-06-18	2008-02-19	Biolipox Ab	composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto
WO2006077366A1 (en)	2005-01-19	2006-07-27	Biolipox Ab	Indoles useful in the treatment of inflammation
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en)	2007-06-04	2008-12-11	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2627848T3 (es)	2008-06-04	2017-07-31	Synergy Pharmaceuticals Inc.	Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es)	2008-07-16	2017-07-17	Synergy Pharmaceuticals Inc.	Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
EP2487159A1 (en) *	2011-02-11	2012-08-15	MSD Oss B.V.	RorgammaT inhibitors
EP2548877A1 (en)	2011-07-19	2013-01-23	MSD Oss B.V.	4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
WO2014026328A1 (en)	2012-08-15	2014-02-20	Merck Sharp & Dohme Corp.	3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
WO2014026329A1 (en) *	2012-08-15	2014-02-20	Merck Sharp & Dohme Corp.	N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
WO2014026330A1 (en)	2012-08-15	2014-02-20	Merck Sharp & Dohme Corp.	3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
WO2014026327A1 (en)	2012-08-15	2014-02-20	Merck Sharp & Dohme Corp.	4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
US9708367B2 (en)	2013-03-15	2017-07-18	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase and their uses
EP2968439A2 (en)	2013-03-15	2016-01-20	Synergy Pharmaceuticals Inc.	Compositions useful for the treatment of gastrointestinal disorders
PL3004138T3 (pl)	2013-06-05	2024-07-29	Bausch Health Ireland Limited	Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
CA2975997A1 (en)	2015-02-11	2016-08-18	Merck Sharp & Dohme Corp.	Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
JP2018531958A (ja)	2015-10-27	2018-11-01	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	ＲＯＲγＴ阻害薬としてのヘテロアリール置換安息香酸及びその使用
US10287272B2 (en)	2015-10-27	2019-05-14	Merck Sharp & Dohme Corp.	Substituted indazole compounds as RORgammaT inhibitors and uses thereof
EP3368516B1 (en)	2015-10-27	2020-07-15	Merck Sharp & Dohme Corp.	SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
TWI908740B (zh) *	2019-10-09	2025-12-21	美商百歐克斯製藥公司	口服補體因子d抑制劑

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2045244B (en) *	1979-03-07	1983-01-26	Pfizer Ltd	3-1-(imidazolylalkyl) indoles
DE3531658A1 (de) *	1985-09-05	1987-03-12	Boehringer Mannheim Gmbh	Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel
CA1334092C (en) *	1986-07-11	1995-01-24	David John Carini	Angiotensin ii receptor blocking imidazoles
NZ221729A (en) *	1986-09-15	1989-07-27	Janssen Pharmaceutica Nv	Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
GB8724912D0 (en) *	1987-10-23	1987-11-25	Wellcome Found	Indole derivatives
PH31175A (en) *	1990-10-31	1998-03-20	Squibb & Sons Inc	Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.

1990
- 1990-11-15 PT PT95899A patent/PT95899A/pt not_active Application Discontinuation
- 1990-11-16 NZ NZ236117A patent/NZ236117A/en unknown
- 1990-11-16 IE IE414690A patent/IE904146A1/en unknown
- 1990-11-16 NO NO90904987A patent/NO904987L/no unknown
- 1990-11-16 EP EP19900312489 patent/EP0429257A3/en not_active Withdrawn
- 1990-11-16 CA CA002030177A patent/CA2030177A1/en not_active Abandoned
- 1990-11-16 AU AU66669/90A patent/AU638510B2/en not_active Ceased
- 1990-11-16 FI FI905672A patent/FI905672A7/fi not_active IP Right Cessation
- 1990-11-16 KR KR1019900018689A patent/KR910009692A/ko not_active Withdrawn
- 1990-11-17 JP JP2312594A patent/JPH03271288A/ja active Pending
- 1990-11-18 IL IL96385A patent/IL96385A0/xx unknown

Also Published As

Publication number	Publication date
IL96385A0 (en)	1991-08-16
AU6666990A (en)	1991-05-23
CA2030177A1 (en)	1991-05-18
FI905672A7 (fi)	1991-05-18
EP0429257A2 (en)	1991-05-29
AU638510B2 (en)	1993-07-01
JPH03271288A (ja)	1991-12-03
NZ236117A (en)	1992-09-25
KR910009692A (ko)	1991-06-28
EP0429257A3 (en)	1992-01-29
FI905672A0 (fi)	1990-11-16
IE904146A1 (en)	1991-05-22
PT95899A (pt)	1991-09-13
NO904987D0 (no)	1990-11-16

Publication	Publication Date	Title
NO904987D0 (no)	1990-11-16	Fremgangsmaate for fremstilling av indolderivater.
NO913234D0 (no)	1991-08-19	Fremgangsmaate for fremstilling av pyrazolderivater.
NO892936L (no)	1990-01-19	Fremgangsmaate for fremstilling av furanderivater.
NO902003D0 (no)	1990-05-07	Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO901554L (no)	1990-10-08	Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO904285D0 (no)	1990-10-02	Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO903431D0 (no)	1990-08-03	Fremgangsmaate for fremstilling av kromanderivater.
NO903043L (no)	1991-01-08	Fremgangsmaate for fremstilling av kromanderivater.
NO903275D0 (no)	1990-07-23	Fremgangsmaate for fremstilling av kromanderivater.
NO905377D0 (no)	1990-12-12	Fremgangsmaate for fremstilling av glycerolderivater.
NO905444D0 (no)	1990-12-18	Fremgangsmaate til fremstilling av oksazolderivater.
NO903207D0 (no)	1990-07-18	Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO891588D0 (no)	1989-04-18	Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO901690D0 (no)	1990-04-17	Fremgangsmaate til fremstilling av substituerte azetidinylisotiazolpyridon-derivater.
NO913692D0 (no)	1991-09-19	Fremgangsmaate for fremstilling av karbapenemforbindelser.
NO902762D0 (no)	1990-06-21	Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO900969L (no)	1990-09-04	Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO901067L (no)	1990-09-10	Fremgangsmaate for fremstilling av tiofener.
NO904060L (no)	1991-03-20	Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO900381D0 (no)	1990-01-26	Fremgangsmaate for fremstilling av nafthalenderivater.
NO911672D0 (no)	1991-04-26	Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO894707L (no)	1990-05-28	Fremgangsmaate for fremstilling av benzoksazinderivater.
NO905047L (no)	1991-05-23	Fremgangsmaate for fremstilling av selenofenderivater.
NO904070L (no)	1991-03-20	Fremgangsmaate for fremstilling av alkanfenoner.
NO904362D0 (no)	1990-10-08	Fremgangsmaate for fremstilling av kromanderivater.